Flexible Solutions for Your Immuno-Oncology Needs

left-img-white-paper-complementary-diagnostics

White paper: Role of biomarkers, companion and complementary diagnostics

Highlights of personalized medicine in immuno-oncology 

1. Precision medicine – Biomarker and CDx assay development 2. Clinical trial expertise – >20 tumor types and 11 immuno-oncology drug classes 3. Dedicated team of experts – Support development gaps and obstacles 4. Full-service partnerships – Reduce development time and cost
Contact Us

Understand the role of a CRO across all phases of immuno-oncology drug development

Steven Anderson PhD, Chief Scientific Officer

icon-case-study

Case Study: Delivering Unique Field Reimbursement Solutions

Case study: Flexibility for a successful partnership

Establishing market presence and delivering strategic reimbursement solutions in immuno-oncology

icon-immuno-oncology-expertise

Immuno-oncology expertise infographic

left-img-capabilities

Discover our expertise in immuno-oncology drug development

icon-white-paper

White paper: Overcoming immuno-oncology challenges

left-img-case-study-addressing-immunotherapy

Evidence-based approaches to address challenges in immuno-oncology